SpliceBio raised €118M in a Series B round in Jun 2025. The company is based in Barcelona, Spain. Investors in the round: Asabys Partners, EQT Life Sciences, Gilde Healthcare and 6 others. Data as of 6 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
